---

Exhibit 31.1



CERTIFICATION OF THE PRESIDENT PURSUANT TO RULE 13A-14 OR
15D-14 OF THE 
SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF 
THE SARBANES-OXLEY ACT OF 2002

I, Lindsay Semple, certify that:

1. I have reviewed this annual report on Form 20-F of Global
  Precision Medical Inc.;
2. Based on my knowledge, this report does not contain any
  untrue statement of a material fact or omit to state a material fact necessary
  to make the statements made, in light of the circumstances under which such
  statements were made, not misleading with respect to the period covered by
  this report;
3. Based on my knowledge, the financial statements, and other
  financial information included in this quarterly report, fairly present in all
  material respects the financial condition, results of operations and cash
  flows of the Registrant as of, and for, the periods presented in this report.
4. The Registrant's other certifying officer and I are
  responsible for establishing and maintaining disclosure controls and
  procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and
  internal control over financial reporting (as defined in Exchange Act Rules
  13a-15(f) and 15(d)-15(f))for the Registrant and have:

> Designed such disclosure controls and procedures, or
>     caused such disclosure controls and procedures to be designed under our
>     supervision, to ensure that material information relating to the Registrant,
>     including its consolidated subsidiaries, is made known to us by others
>     within those entities, particularly during the period in which this report
>     is being prepared;
>     Designed such internal control over financial reporting,
>     or caused such internal control over financial reporting to be designed
>     under our supervision, to provide reasonable assurance regarding the
>     reliability of financial reporting and the preparation of financial
>     statements for external purposes in accordance with generally accepted
>     accounting principles;
>     Evaluated the effectiveness of the Registrant's
>     disclosure controls and procedures and presented in this report our
>     conclusions about the effectiveness of the disclosure controls and
>     procedures, as of the end of the period covered by this report based on such
>     evaluation; and
>     Disclosed in this report any change in the Registrant's
>     internal control over financial reporting that occurred during the
>     Registrant's most recent fiscal quarter that has materially affected, or is
>     reasonably likely to materially affect, the Registrant's internal control
>     over financial reporting; and

1. The Registrant's other certifying officer and I have
  disclosed, based on our most recent evaluation of internal control over
  financial reporting, to the Registrant's auditors and the audit committee of
  the Registrant's board of directors (or persons performing the equivalent
  functions):

> All significant deficiencies and material weaknesses in
>     the design or operation of internal control over financial reporting which
>     are reasonably likely to adversely affect the Registrant's ability to
>     record, process, summarize and report financial information; and
>     Any fraud, whether or not material, that involves
>     management or other employees who have a significant role in the
>     Registrant's internal control over financial reporting.

Date:
      September 2, 2003
      
      /s/ Lindsay SempleLindsay Semple
      Chief Executive Officer